These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 10721942)

  • 1. Sentinel node biopsy guided by indocyanine green dye in breast cancer patients.
    Motomura K; Inaji H; Komoike Y; Kasugai T; Noguchi S; Koyama H
    Jpn J Clin Oncol; 1999 Dec; 29(12):604-7. PubMed ID: 10721942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Axillary lymph node recurrence after sentinel lymph node biopsy performed using a combination of indocyanine green fluorescence and the blue dye method in early breast cancer.
    Inoue T; Nishi T; Nakano Y; Nishimae A; Sawai Y; Yamasaki M; Inaji H
    Breast Cancer; 2016 Mar; 23(2):295-300. PubMed ID: 25348937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Indocyanine green fluorescence mapping for sentinel lymph node biopsy in early breast cancer.
    Pitsinis V; Provenzano E; Kaklamanis L; Wishart GC; Benson JR
    Surg Oncol; 2015 Dec; 24(4):375-9. PubMed ID: 26555151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional lymphatic anatomy for sentinel node biopsy in breast cancer: echoes from the past and the periareolar blue method.
    Borgstein PJ; Meijer S; Pijpers RJ; van Diest PJ
    Ann Surg; 2000 Jul; 232(1):81-9. PubMed ID: 10862199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the indocyanine green fluorescence and blue dye methods in detection of sentinel lymph nodes in early-stage breast cancer.
    Sugie T; Sawada T; Tagaya N; Kinoshita T; Yamagami K; Suwa H; Ikeda T; Yoshimura K; Niimi M; Shimizu A; Toi M
    Ann Surg Oncol; 2013 Jul; 20(7):2213-8. PubMed ID: 23429938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biopsy method and excision volume do not affect success rate of subsequent sentinel lymph node dissection in breast cancer.
    Haigh PI; Hansen NM; Qi K; Giuliano AE
    Ann Surg Oncol; 2000; 7(1):21-7. PubMed ID: 10674444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High rate of solitary sentinel node metastases identification by fluorescence-guided lymphatic imaging in breast cancer.
    Hirche C; Mohr Z; Kneif S; Murawa D; Hünerbein M
    J Surg Oncol; 2012 Feb; 105(2):162-6. PubMed ID: 21882198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sentinel lymph node biopsy for breast cancer patients using fluorescence navigation with indocyanine green.
    Aoyama K; Kamio T; Ohchi T; Nishizawa M; Kameoka S
    World J Surg Oncol; 2011 Dec; 9():157. PubMed ID: 22132943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors predicting non-sentinel lymph node involvement in sentinel node positive breast carcinoma.
    Durak MG; Akansu B; Akin MM; Sevınç AI; Koçdor MA; Saydam S; Harmancioğlu O; Ellıdokuz H; Bekış R; Canda T
    Turk Patoloji Derg; 2011; 27(3):189-95. PubMed ID: 21935867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Demonstration of the sentinel lymph node in axillary dissection for breast cancer].
    Salmon RJ; Fried D
    Presse Med; 1998 Mar; 27(11):509-12. PubMed ID: 9767960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Initial experience with sentinel node biopsy in breast cancer at the National Cancer Center Hospital East.
    Imoto S; Hasebe T
    Jpn J Clin Oncol; 1999 Jan; 29(1):11-5. PubMed ID: 10073145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical utility of the additional use of blue dye for indocyanine green for sentinel node biopsy in breast cancer.
    Ji Y; Luo N; Jiang Y; Li Q; Wei W; Yang H; Liu J
    J Surg Res; 2017 Jul; 215():88-92. PubMed ID: 28688667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors for extensive nodal involvement in breast cancer patients with axillary lymph node metastases.
    Verheuvel NC; Ooms HW; Tjan-Heijnen VC; Roumen RM; Voogd AC
    Breast; 2016 Jun; 27():175-81. PubMed ID: 27123958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.
    Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F
    J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Initial experience in a cancer hospital in Nepal with sentinel lymph node mapping and biopsy for evaluation of axillary lymph node status in palpable invasive breast cancer.
    Lamichhane N; Pradhan M; Neupane PR; Shrestha BM; Dhakal HP; Thakur BK; Cox CE
    Nepal Med Coll J; 2007 Mar; 9(1):22-6. PubMed ID: 17593673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors affecting failed localisation and false-negative rates of sentinel node biopsy in breast cancer--results of the ALMANAC validation phase.
    Goyal A; Newcombe RG; Chhabra A; Mansel RE;
    Breast Cancer Res Treat; 2006 Sep; 99(2):203-8. PubMed ID: 16541308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sentinel node biopsy versus low axillary sampling in women with clinically node negative operable breast cancer.
    Parmar V; Hawaldar R; Nair NS; Shet T; Vanmali V; Desai S; Gupta S; Rangrajan V; Mittra I; Badwe RA
    Breast; 2013 Dec; 22(6):1081-6. PubMed ID: 23948301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Sentinel lymphatic node biopsy for breast cancer in practice].
    Strnad P; Rob L; Krízová H; Zuntová A; Chod J; Halaska M
    Ceska Gynekol; 2005 Jul; 70(4):291-5. PubMed ID: 16128130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of sentinel lymph node biopsy guided by the multimodal method of indocyanine green fluorescence, radioisotope, and blue dye versus the radioisotope method in breast cancer: a randomized controlled trial.
    Jung SY; Kim SK; Kim SW; Kwon Y; Lee ES; Kang HS; Ko KL; Shin KH; Lee KS; Park IH; Ro J; Jeong HJ; Joo J; Kang SH; Lee S
    Ann Surg Oncol; 2014 Apr; 21(4):1254-9. PubMed ID: 24356798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blue nodes left behind after vital blue dye-guided axillary sentinel node biopsy in breast cancer patients.
    Cserni G; Rajtár M; Boross G
    Jpn J Clin Oncol; 2000 Jun; 30(6):263-6. PubMed ID: 10939430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.